Helikos S.E. (ETR:EXC) | WebDisclosure

Basculer en Français

10800	Companies
233619	Keywords
162289	Articles
124731	Press releases

Home
Companies
Helikos S.E.

PRESS RELEASE

published on 05/28/2024 at 18:43, 2 years 2 months ago

H2APEX generated strong revenue growth in Q1 2024 and confirms revenue guidance for FY 2024 of EUR 35 million to EUR 40 million
H2APEX reports strong revenue growth in Q1 2024, doubling to EUR 10.1 million. Confirms revenue guidance of EUR 35-40 million for FY 2024. Expansion plans and operations are on track

Revenue Growth Revenue Guidance Green Hydrogen Plants H2APEX Q1 2024
PRESS RELEASE

published on 05/22/2024 at 13:01, 2 years 2 months ago

Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung für H2APEX Group SCA mit Kursziel von 9,00 Euro nach Veröffentlichung des Jahresberichts und Update der Schätzungen

First Berlin Equity Research Kaufempfehlung H2APEX Group SCA Jahresbericht Schätzungen
BRIEF

published on 05/01/2024 at 07:55, 2 years 3 months ago

H2APEX Confirms Revenue Growth and Outlines Future Strategy

Revenue Growth Green Hydrogen Sustainable Energy H2APEX Fiscal Report
BRIEF

published on 05/01/2024 at 07:55, 2 years 3 months ago

H2APEX confirme la croissance de ses revenus et présente sa stratégie future

Rapport Financier H2APEX Hydrogène Vert Hausse Des Revenus L'énergie Durable
PRESS RELEASE

published on 05/01/2024 at 07:50, 2 years 3 months ago

H2APEX confirms both its preliminary figures for the fiscal year 2023 and its forecast for 2024 – and expects revenue to more than double
H2APEX confirms preliminary figures for 2023 fiscal year and forecasts revenue to more than double in 2024, focusing on green hydrogen plants and storage solutions

Storage Solutions Revenue Forecast Green Hydrogen 2023 Fiscal Year H2APEX Group SCA
PRESS RELEASE

published on 03/13/2024 at 13:41, 2 years 4 months ago

Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung für H2APEX Group SCA mit Kursziel von 9,00 Euro nach starkem Umsatzwachstum und EU-Genehmigung für Wasserstoffprojekt

Kursziel Kaufempfehlung Umsatzwachstum H2APEX Group SCA EU-Genehmigung
BRIEF

published on 03/05/2024 at 08:36, 2 years 4 months ago

H2APEX Achieves 2023 Revenue Forecasts and Anticipates Doubling Earnings in 2024

Revenue Forecast Green Hydrogen H2APEX Financial Growth Hydrogen Plants
BRIEF

published on 03/05/2024 at 08:36, 2 years 4 months ago

H2APEX atteint ses prévisions de revenus pour 2023 et prévoit un doublement de ses bénéfices en 2024

Croissance Financière H2APEX Hydrogène Vert Prévisions De Revenus Usines D'hydrogène
PRESS RELEASE

published on 03/05/2024 at 08:31, 2 years 4 months ago

H2APEX meets forecast for the fiscal year 2023 and expects revenue to more than double in 2024
H2APEX meets forecast for fiscal year 2023, expects revenue to more than double in 2024. Company positioning for growth in green hydrogen sector

Revenue Growth Green Hydrogen Forecast Financial Outlook H2APEX
PRESS RELEASE

published on 02/19/2024 at 09:51, 2 years 5 months ago

Original-Research: H2APEX Group SCA (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research bestätigt Kaufempfehlung und erhöht Kursziel für H2APEX Group SCA nach EU-Genehmigung von H2ERO-Projekt mit Förderung und geplantem Investitionsvolumen

First Berlin Equity Research Kursziel Kaufempfehlung H2ERO-Projekt EU-Genehmigung

Accesswire

Published on 08/05/2026 at 02:10, 43 minutes ago

Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance
Published on 08/04/2026 at 22:30, 4 hours 23 minutes ago

Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 22:00, 4 hours 53 minutes ago

Lockheed Martin and NioCorp Sign MOU
Published on 08/04/2026 at 17:00, 9 hours 53 minutes ago

Moderna annonce le début d'un essai clinique de phase 1 portant sur l’ARNm-1469, son vaccin expérimental contre l'ébolavirus de Bundibugyo
Published on 08/04/2026 at 16:25, 10 hours 28 minutes ago

ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026

View all ACCESSWIRE

EQS Group

Published on 08/04/2026 at 22:03, 4 hours 49 minutes ago

#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 4 hours 51 minutes ago

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 6 hours 47 minutes ago

Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:40, 7 hours 12 minutes ago

NNS acquires shares in OCI
Published on 08/04/2026 at 19:39, 7 hours 13 minutes ago

EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again

Les Echos

Published on 08/04/2026 at 19:16, 7 hours 37 minutes ago

Covivio - 2026 Half-year financial report
Published on 08/04/2026 at 19:16, 7 hours 37 minutes ago

Covivio - Rapport financier semestriel 2026
Published on 08/04/2026 at 18:32, 8 hours 20 minutes ago

Capital et droits de vote au 31 juillet 2026
Published on 08/04/2026 at 18:32, 8 hours 20 minutes ago

Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 9 hours 8 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE